Drug Elution Data From Europe:
A Review of Data Shown at LINC & Charing Cross

From 12-month Elegance Registry findings to 24-month SPORTS data, plus a fresh meta-analysis on femoropopliteal stenting. Top experts unpack the results debuted at LINC & Charing Cross and what they mean for your patients.

Moderator: Sean Lyden, MD

Speakers/Panelists: Marc P. Bonaca, MD, MPH; Andrew Holden, MBChB; D. Christopher Metzger, MD;
Leigh Ann O’Banion, MD; Parag Patel, MD; Eric Secemsky, MD, MSc

Agenda

Introduction
Sean Lyden, MD

Performance of Stenting in Femoropopliteal Disease:
Systemic Review and Meta-Analysis
Andrew Holden, MBChB

Treatment of In-Stent Restenosis With the Ranger Balloon:
12-Month Data From the Elegance Registry
Eric Secemsky, MD, MSc

24-Month Data From the SPORTS Trial
Leigh Ann O’Banion, MD

Click Here to Register